These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

545 related articles for article (PubMed ID: 30130411)

  • 1. Mitogen-activated Protein Kinase-activated Protein Kinase 2 Inhibition Attenuates Fibroblast Invasion and Severe Lung Fibrosis.
    Liang J; Liu N; Liu X; Mena JM; Xie T; Geng Y; Huan C; Zhang Y; Taghavifar F; Huang G; Kurkciyan A; Barron V; Jiang D; Noble PW
    Am J Respir Cell Mol Biol; 2019 Jan; 60(1):41-48. PubMed ID: 30130411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide-mediated inhibition of mitogen-activated protein kinase-activated protein kinase-2 ameliorates bleomycin-induced pulmonary fibrosis.
    Vittal R; Fisher A; Gu H; Mickler EA; Panitch A; Lander C; Cummings OW; Sandusky GE; Wilkes DS
    Am J Respir Cell Mol Biol; 2013 Jul; 49(1):47-57. PubMed ID: 23470623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Follistatin-Like 1 Promotes Bleomycin-Induced Pulmonary Fibrosis through the Transforming Growth Factor Beta 1/Mitogen-Activated Protein Kinase Signaling Pathway.
    Jin YK; Li XH; Wang W; Liu J; Zhang W; Fang YS; Zhang ZF; Dai HP; Ning W; Wang C
    Chin Med J (Engl); 2018 Aug; 131(16):1917-1925. PubMed ID: 30082522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe lung fibrosis requires an invasive fibroblast phenotype regulated by hyaluronan and CD44.
    Li Y; Jiang D; Liang J; Meltzer EB; Gray A; Miura R; Wogensen L; Yamaguchi Y; Noble PW
    J Exp Med; 2011 Jul; 208(7):1459-71. PubMed ID: 21708929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MMI-0100 inhibits cardiac fibrosis in myocardial infarction by direct actions on cardiomyocytes and fibroblasts via MK2 inhibition.
    Xu L; Yates CC; Lockyer P; Xie L; Bevilacqua A; He J; Lander C; Patterson C; Willis M
    J Mol Cell Cardiol; 2014 Dec; 77():86-101. PubMed ID: 25257914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of dual-specificity protein phosphatase DUSP10/MKP-5 in pulmonary fibrosis.
    Xylourgidis N; Min K; Ahangari F; Yu G; Herazo-Maya JD; Karampitsakos T; Aidinis V; Binzenhöfer L; Bouros D; Bennett AM; Kaminski N; Tzouvelekis A
    Am J Physiol Lung Cell Mol Physiol; 2019 Nov; 317(5):L678-L689. PubMed ID: 31483681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD148 Deficiency in Fibroblasts Promotes the Development of Pulmonary Fibrosis.
    Tsoyi K; Liang X; De Rossi G; Ryter SW; Xiong K; Chu SG; Liu X; Ith B; Celada LJ; Romero F; Robertson MJ; Esposito AJ; Poli S; El-Chemaly S; Perrella MA; Shi Y; Whiteford J; Rosas IO
    Am J Respir Crit Care Med; 2021 Aug; 204(3):312-325. PubMed ID: 33784491
    [No Abstract]   [Full Text] [Related]  

  • 8. Lack of MK2 inhibits myofibroblast formation and exacerbates pulmonary fibrosis.
    Liu T; Warburton RR; Guevara OE; Hill NS; Fanburg BL; Gaestel M; Kayyali US
    Am J Respir Cell Mol Biol; 2007 Nov; 37(5):507-17. PubMed ID: 17600313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pivotal role of connective tissue growth factor in lung fibrosis: MAPK-dependent transcriptional activation of type I collagen.
    Ponticos M; Holmes AM; Shi-wen X; Leoni P; Khan K; Rajkumar VS; Hoyles RK; Bou-Gharios G; Black CM; Denton CP; Abraham DJ; Leask A; Lindahl GE
    Arthritis Rheum; 2009 Jul; 60(7):2142-55. PubMed ID: 19565505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sunitinib, a Small-Molecule Kinase Inhibitor, Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice.
    Huang X; Wang W; Yuan H; Sun J; Li L; Wu X; Luo J; Gu Y
    Tohoku J Exp Med; 2016 Aug; 239(4):251-61. PubMed ID: 27439438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycosyltransferases and glycosaminoglycans in bleomycin and transforming growth factor-β1-induced pulmonary fibrosis.
    Venkatesan N; Tsuchiya K; Kolb M; Farkas L; Bourhim M; Ouzzine M; Ludwig MS
    Am J Respir Cell Mol Biol; 2014 Mar; 50(3):583-94. PubMed ID: 24127863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tackling MARCKS-PIP3 circuit attenuates fibroblast activation and fibrosis progression.
    Yang DC; Li JM; Xu J; Oldham J; Phan SH; Last JA; Wu R; Chen CH
    FASEB J; 2019 Dec; 33(12):14354-14369. PubMed ID: 31661644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smooth muscle alpha-actin expression and myofibroblast differentiation by TGFbeta are dependent upon MK2.
    Sousa AM; Liu T; Guevara O; Stevens J; Fanburg BL; Gaestel M; Toksoz D; Kayyali US
    J Cell Biochem; 2007 Apr; 100(6):1581-92. PubMed ID: 17163490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GRK2 promotes activation of lung fibroblast cells and contributes to pathogenesis of pulmonary fibrosis through increasing Smad3 expression.
    Li Y; Sun Y; Wu N; Ma H
    Am J Physiol Cell Physiol; 2022 Jan; 322(1):C63-C72. PubMed ID: 34852209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The anti-fibrotic effects of microRNA-153 by targeting TGFBR-2 in pulmonary fibrosis.
    Liang C; Li X; Zhang L; Cui D; Quan X; Yang W
    Exp Mol Pathol; 2015 Oct; 99(2):279-85. PubMed ID: 26216407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human airway trypsin-like protease exerts potent, antifibrotic action in pulmonary fibrosis.
    Menou A; Flajolet P; Duitman J; Justet A; Moog S; Jaillet M; Tabèze L; Solhonne B; Garnier M; Mal H; Mordant P; Castier Y; Cazes A; Sallenave JM; Mailleux AA; Crestani B
    FASEB J; 2018 Mar; 32(3):1250-1264. PubMed ID: 29122847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention and treatment of bleomycin-induced pulmonary fibrosis with the lactate dehydrogenase inhibitor gossypol.
    Judge JL; Nagel DJ; Owens KM; Rackow A; Phipps RP; Sime PJ; Kottmann RM
    PLoS One; 2018; 13(5):e0197936. PubMed ID: 29795645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth differentiation factor 15 facilitates lung fibrosis by activating macrophages and fibroblasts.
    Takenouchi Y; Kitakaze K; Tsuboi K; Okamoto Y
    Exp Cell Res; 2020 Jun; 391(2):112010. PubMed ID: 32305327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotrophic tyrosine kinase receptor B/neurotrophin 4 signaling axis is perturbed in clinical and experimental pulmonary fibrosis.
    Avcuoglu S; Wygrecka M; Marsh LM; Günther A; Seeger W; Weissmann N; Fink L; Morty RE; Kwapiszewska G
    Am J Respir Cell Mol Biol; 2011 Oct; 45(4):768-80. PubMed ID: 21330466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Megakaryoblastic leukemia-1 is required for the development of bleomycin-induced pulmonary fibrosis.
    Bernau K; Ngam C; Torr EE; Acton B; Kach J; Dulin NO; Sandbo N
    Respir Res; 2015 Mar; 16(1):45. PubMed ID: 25885656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.